<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.01">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.01" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-107876-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Afri-Can Forum 2.0 : Programme de Subventions de renforcement des capacit&#xE9;s en vue d&apos;essais cliniques en mati&#xE8;re de pr&#xE9;vention du VIH/sida</narrative>
   <narrative xml:lang="EN">Afri-Can Forum 2.0: HIV/AIDS Prevention Trials Capacity Building Grants Program</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&apos;&#xE9;pid&#xE9;mie de sida continue de toucher l&apos;Afrique plus que tout autre continent et la pr&#xE9;vention du VIH/sida demeure une priorit&#xE9; sanitaire mondiale. Ce projet appuiera la recherche continue sur le VIH/sida et l&apos;&#xE9;change de renseignements lors de l&apos;Afri-Can Forum 2.0 en f&#xE9;vrier 2015.

Recherche pour sauver des vies
Le forum permettra aux chercheurs participant &#xE0; la deuxi&#xE8;me phase du programme Subventions de renforcement des capacit&#xE9;s en vue d&apos;essais cliniques en mati&#xE8;re de pr&#xE9;vention du VIH/sida d&apos;&#xE9;changer leurs r&#xE9;sultats avec des b&#xE9;n&#xE9;ficiaires de subventions et autres des Instituts de recherche en sant&#xE9; du Canada, tels que les participants de la Bill &amp; Melinda Gates Foundation et du Partenariat des pays europ&#xE9;ens et en d&#xE9;veloppement sur les essais cliniques. 

L&apos;Initiative de recherche en sant&#xE9; mondiale (IRSM) g&#xE8;re le programme, aid&#xE9;e par le financement d&apos;Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada. L&apos;objectif est d&apos;aider &#xE0; cr&#xE9;er des comp&#xE9;tences, des connaissances et un leadership africains durables pour mener les futurs essais visant la pr&#xE9;vention du VIH/sida. Ce programme cherche &#xE0; soutenir la collaboration entre les chercheurs africains et les utilisateurs de la recherche en Afrique concernant ces essais. Il vise &#xE9;galement &#xE0; am&#xE9;liorer la collaboration mondiale sur les essais pour la pr&#xE9;vention du VIH/sida entre les chercheurs et institutions canadiens et africains. 

&#xC0; propos de l&apos;Afri-Can Forum
Ce projet s&apos;appuie sur la r&#xE9;ussite du premier Afri-Can Forum, auquel ont particip&#xE9; pr&#xE8;s de 130 personnes, y compris des repr&#xE9;sentants d&apos;organismes de recherche et des donateurs internationaux. Le Wits Health Consortium en Afrique du Sud organisera ce deuxi&#xE8;me forum, qui comptera des s&#xE9;ances pl&#xE9;ni&#xE8;res, des pr&#xE9;sentations de r&#xE9;sum&#xE9;s, des discussions de groupe et des pr&#xE9;sentations par affiches. 

Les participants partageront les r&#xE9;sultats de la recherche soutenue par l&apos;IRSM. Le forum servira &#xE0; consolider la collaboration entre r&#xE9;gions pour renforcer l&apos;incidence de la pr&#xE9;vention du VIH.</narrative>
   <narrative xml:lang="EN">The AIDS epidemic continues to affect Africa more than any other continent, and HIV/AIDS prevention remains a global health priority. This project will support continued HIV/AIDS research and information-sharing at the Afri-Can Forum 2.0 in February 2015.

Life-saving research
The forum will allow researchers who are part of the HIV/AIDS Prevention Trials Capacity Building Grants Phase 2 program to exchange results with Canadian Institutes of Health Research grantees and others, such as participants from the Bill &amp; Melinda Gates Foundation and the European and Developing Countries Clinical Trials Partnership. 

The Global Health Research Initiative (GHRI) manages the program with funding from the Foreign Affairs, Trade and Development Canada. The goal is to help create sustainable African skills, knowledge, and leadership to conduct future HIV/AIDS prevention trials. This program seeks to support collaboration among African researchers and research users in HIV/AIDS prevention trials. It also aims to increase global HIV/AIDS prevention trial collaboration among Canadian and African researchers and institutions. 

About the Afri-Can Forum
This project builds on the success of the first Afri-Can Forum attended by close to 130 participants, including representatives from research organizations and international donors. The Wits Health Consortium in South Africa will organize this second forum, which features plenary and abstract presentations, panel discussions, and poster viewing sessions. 

Participants will share the results of GHRI-supported research. The forum will serve to reinforce inter-regional collaboration for greater HIV prevention impact.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="23">
   <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
  </participating-org>
  <participating-org role="4" type="23">
   <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-12-15" type="2"></activity-date>
  <activity-date iso-date="2015-03-15" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="3"></activity-scope>
  <recipient-region code="XE" percentage="100" vocabulary="1"></recipient-region>
  <sector code="00003" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Children and Youth</narrative>
   <narrative xml:lang="FR">Enfants et jeunes</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="101" significance="2" vocabulary="99"></policy-marker>
  <policy-marker code="102" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="103" significance="0" vocabulary="99"></policy-marker>
  <policy-marker code="104" significance="1" vocabulary="99"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-01-31"></transaction-date>
   <value currency="CAD" value-date="2015-01-31">129895</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-01-31"></transaction-date>
   <value currency="CAD" value-date="2015-01-31">120802.35</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-03-31"></transaction-date>
   <value currency="CAD" value-date="2015-03-31">-9092.65</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-06-30"></transaction-date>
   <value currency="CAD" value-date="2015-06-30">-11697.77</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-07-31"></transaction-date>
   <value currency="CAD" value-date="2015-07-31">-11697.73</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-01-31"></transaction-date>
   <value currency="CAD" value-date="2015-01-31">213605</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-01-31"></transaction-date>
   <value currency="CAD" value-date="2015-01-31">198652.65</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-03-31"></transaction-date>
   <value currency="CAD" value-date="2015-03-31">-14952.35</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2015-06-30"></transaction-date>
   <value currency="CAD" value-date="2015-06-30">-19236.32</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-07-31"></transaction-date>
   <value currency="CAD" value-date="2015-07-31">-19236.27</value>
   <provider-org>
    <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
    <narrative xml:lang="ES">Agencia Canadiense para el Desarrollo Internacional</narrative>
    <narrative xml:lang="EN">Canadian International Development Agency</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Proprietary) Ltd.</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
